期刊文献+

冠心病患者血清同型半胱氨酸、超敏C反应蛋白、脂蛋白(a)及D-二聚体联合检测的意义 被引量:5

Application of homocysteine, serum high sensitive C-reactive protein, lipoprotein A and D-two dimer com- bined detection in the course of coronary heart disease
原文传递
导出
摘要 目的探讨同型半胱氨酸(Hcy)、超敏C-反应蛋白(hs-CRP)、脂蛋白(a)[LP(a)]和D-二聚体(DD)联合检测在冠心病诊疗中的应用价值。方法对180例冠心病患者(冠心病组)和同期来该院体检合格的健康人200例(对照组)分别检测Hcy、hs.CRP、LP(a)和DD水平,比较两组各项检测指标的差异。结果冠心病组Hcy、hs.CRP、LP(a)和DD含量均明显高于对照组(t=13.87、10.24、9.86、18.02,均P〈0.05)。冠心病患者各组间各项指标比较:AMI组明显高于UAP组(t=15.79、9.73、11.47、17.34,均P〈0.05)、UAP组明显高于SAP组(t=16.82、8.14、10.65、18.27,均P〈0.05)、SAP组明显高于SMI组(t=14.36、10.35、9.98、16.52,均P〈0.05)。结论对冠心病患者血清Hcy、hs-CRP、LP(a)和DD联合检测有助于了解冠心病病程发展,评估冠心病风险。 Objective To study the meaning of Homocysteine, serum high sensitive C-reactive protein, lipo- protein A and D-two dimer combined detection in the course of coronary heart disease. Methods Select 180 cases suffering from different types of coronary heart disease as group of coronary heart disease,200 healthy people who were in our hospital physical examination qualified over the same period as the control group, all the cases of fasting venous blood was sampled respectively to detect the content of Hcy, hs-CRP, LP (a) and DD. Results Coronary heart dis- ease group of patients with Hcy, hs-CRP, LP(a) and DD levels were significantly higher than those of the control group of healthy persons ( t = 13.87,10.24,9.86,18.02, P 〈 0.05 ), Comparison among different indicators of the pa- tiens with Coronary heart disease : the group of AMI was higher than the group of UAP ( t = 15.79,9.73,11.47, 17. 34, all P 〈 0.05), the group of UAP was higher than the group of SAP ( t = 16.82,8.14,10.65,18.27, P 〈 0.05),the group of SAP was higher than the group of SMI(t = 14. 36, 10. 35,9. 98, 16. 52,P 〈 0. 05). Conclusion Monitoring of Hcy, hs-CRP, LP(a) and DD for coronary heart disease, contributes to the understand of the development of the course of coronary heart disease and assess the risk of coronary heart disease.
出处 《中国基层医药》 CAS 2013年第6期860-862,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 冠状动脉疾病 高半胱氨酸 C反应蛋白质 脂蛋白(A) D-二聚体 Coronary disease Homocysteine C-reactive protein Lipoprotein(a) D-two dimer
  • 相关文献

参考文献10

二级参考文献88

共引文献100

同被引文献34

  • 1无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2044
  • 2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2108
  • 3Mollmann H, Nef H, Bohm M, et ill. Highlights of the hotlinesessions presented at the scientific sessins 2008 of" the American Heart Association[J]. Cardiology, 2009, 98 ( 1 ) : I-7.
  • 4Rodriguez-Iturbe B,Correa-Rotter R.Cardiovascular risk factors and prevention of cardiovascular disease in patients with chronic renal disease[J].Exp Opin Pharmacoth,2010,11(16):2687-2698.
  • 5Goldstein LB,Bushnell CD,Adams RJ,et al.Guidelines for the primary prevention of stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association.[J].Stroke,2011,42(2):517-584.
  • 6Collaboration E,Erqou S,Kaptoge S,et al.Lipoprotein(a)concentration and the risk of coronary heart disease,stroke,and nonvascular mortality[J].JAMA,2009,302(4):412-423.
  • 7Golovkin AS,Ponasenko AV,Khutornaya MV,et al.Association of TLR and TREM-1 Gene Polymorphisms with Risk of Coronary Artery Disease in a Russian Population[J].Gene,2014,550(1):101-109.
  • 8Mohamed AI,Tariq H,Bansal SS,et al.Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure:critical importance of the cardiosplenic axis[J].Circ Res,2014,114(2):266-282.
  • 9Hochholzer W,Morrow DA,Giugliano RP.Novel biomarkers in cardiovascular disease:Update 2010[J].Am Heart J,2010,160(4):583-594.
  • 10林志芳,岑丽莲,柯尊彬,贾冰,李海珠,帅虎,梅敏.4项指标联合检测诊断冠心病的临床价值[J].检验医学与临床,2008,5(13):781-782. 被引量:2

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部